A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis
Clinical trial NCT02852967 · COMPLETED
Trial details
- NCT number
- NCT02852967
- Sponsor
- Kadmon Corporation, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-14
- Primary completion
- 2019-02-13
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.